Total submissions: 6
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Eurofins Ntd Llc |
RCV000724084 | SCV000228131 | uncertain significance | not provided | 2014-10-31 | criteria provided, single submitter | clinical testing | |
Prevention |
RCV000247012 | SCV000307750 | likely benign | not specified | criteria provided, single submitter | clinical testing | ||
Labcorp Genetics |
RCV001089342 | SCV001002153 | likely benign | Primary ciliary dyskinesia | 2025-01-07 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV001089342 | SCV002620411 | benign | Primary ciliary dyskinesia | 2017-02-28 | criteria provided, single submitter | clinical testing | This alteration is classified as benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Gene |
RCV000724084 | SCV003919551 | uncertain significance | not provided | 2022-10-21 | criteria provided, single submitter | clinical testing | In silico analysis supports that this missense variant has a deleterious effect on protein structure/function; Has not been previously published as pathogenic or benign to our knowledge |
Natera, |
RCV001089342 | SCV001458609 | uncertain significance | Primary ciliary dyskinesia | 2020-01-17 | no assertion criteria provided | clinical testing |